65488-97-3Relevant articles and documents
CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 000388; 000389; 000469; 000470, (2018/01/17)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
NUCLEOTIDES, XIII: PHOSPHORYLATIONS OF ADENOSINE AND 2'-DEOXYADENOSINE BY PHOSPHOROCHLORIDATES
Charubala, Ramamurthy,Pfleiderer, Wolfgang
, p. 761 - 776 (2007/10/02)
Phosphorylations of adenosine and 2'-deoxyadenosine by various phosphorylating agents such as diphenylphosphorochloridate have been achieved at positions 3', 5'and N6 using appropiate starting materials for unambiguous synthesis.There is a grad